Financial News
Latest News about MNMD
Recent news which mentions MNMD
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
From Benzinga
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety
October 27, 2021
From Benzinga
These 4 Psychedelic Biotech Stocks Are Leading the Pack
October 26, 2021
From Motley Fool
Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race
October 20, 2021
From Benzinga
7 Penny Stocks to Buy – While They’re Still Penny Stocks
October 19, 2021
From InvestorPlace
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
3 Penny Stocks Waiting on FDA Approval for Rocket Fuel
October 18, 2021
From InvestorPlace
From Benzinga
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
October 11, 2021
From Benzinga
Former Tilray CEO Joins Psychedelics Company
October 07, 2021
From Benzinga
7 Penny Stocks to Pick Up if You Have $100 to Spare
October 07, 2021
From InvestorPlace
MindMed Teams Up With Sphere Health To Identify Biomarkers Associated With Anxiety & Depression
October 05, 2021
Tickers
MNMD
From Benzinga
From Benzinga
From Benzinga
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
October 01, 2021
From Benzinga
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference
September 30, 2021
From Benzinga
Digital Therapeutics And The Future Of Psychedelic Medicine
September 29, 2021
Tickers
MNMD
From Benzinga
From InvestorPlace
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
September 27, 2021
From Benzinga
7 of the Best Penny Stocks to Buy Coming Into Year-End
September 21, 2021
Tags
NYSEAMERICAN:EMAN,NASDAQ:BOXL,NASDAQ:XELA,NASDAQ:MNMD,NASDAQ:BIOC,NASDAQ:EBON,OTCMKTS:UURAF,NYSE:DGX
BIOC
MNMD
From InvestorPlace
Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0
September 15, 2021
From Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
From Benzinga
7 Penny Stocks Waiting on The FDA for Rocket Fuel
September 09, 2021
From InvestorPlace
Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A
September 07, 2021
From Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
From Benzinga
From Benzinga
MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients
August 24, 2021
From Benzinga
Cramer Weighs In On RealReal, Affirm Holdings And More
August 17, 2021
From Benzinga
Push the Boundaries of DMT Therapy with Mind Medicine
August 16, 2021
Tickers
MNMD
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
